Michael W Lipp

Title: Innovations by Michael W. Lipp

Introduction

Michael W. Lipp is an accomplished inventor based in Quincy, MA, known for his contributions to the field of inhalation research. He holds two patents that focus on the formulation of large porous particles suitable for pulmonary delivery. His work has significant implications for therapeutic, prophylactic, and diagnostic applications.

Latest Patents

One of Michael Lipp's latest patents involves a formulation for spray-drying large porous particles. These particles have a tap density of less than about 0.4 g/cm3 and are created from a colloidal solution that includes a carboxylic acid or its salt, a phospholipid, a divalent salt, and a solvent such as an aqueous-organic solvent. The colloidal solution can also incorporate a therapeutic, prophylactic, or diagnostic agent. Preferred carboxylic acids in this formulation contain at least two carboxyl groups. The phospholipids used include phosphatidylcholines, phosphatidylethanolamines, phosphatidylglycerols, phosphatidylserines, phosphatidylinositols, and their combinations. These particles are specifically designed for pulmonary delivery.

Career Highlights

Michael W. Lipp is associated with Advanced Inhalation Research, Inc., where he continues to innovate in the field of inhalation therapies. His expertise in formulating particles for drug delivery has positioned him as a key figure in this specialized area of research.

Collaborations

Michael has collaborated with notable colleagues such as Richard P. Batycky and Giovanni Caponetti, contributing to advancements in inhalation research and particle formulation.

Conclusion

Michael W. Lipp's work in developing formulations for spray-drying large porous particles showcases his innovative spirit and dedication to improving pulmonary delivery systems. His contributions are paving the way for future advancements in inhalation therapies.